Viewing Study NCT03616132


Ignite Creation Date: 2025-12-24 @ 9:34 PM
Ignite Modification Date: 2026-02-19 @ 7:56 AM
Study NCT ID: NCT03616132
Status: UNKNOWN
Last Update Posted: 2018-08-06
First Post: 2018-07-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A First-in-Man Study to Evaluate the Feasibility and Safety of Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System
Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: IBS-FIM-MY
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators